4503 — Astellas Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapNeutral

Annual balance sheet for Astellas Pharma, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	C2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	324,943	326,128	318,267	376,946	335,780
Net Total Accounts Receivable
Net Total Receivables	373,505	362,722	423,018	465,455	576,726
Total Inventory
Total Other Current Assets
Total Current Assets	867,514	872,588	923,354	1,049,954	1,194,730
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	268,600	264,623	269,044	286,459	293,742
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	2,315,169	2,273,628	2,332,395	2,456,518	3,569,603
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	798,708	592,372	687,411	726,034	1,285,725
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	1,026,001	887,513	872,087	948,564	1,973,615
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	1,289,168	1,386,115	1,460,308	1,507,954	1,595,988
Total Liabilities & Shareholders' Equity	2,315,169	2,273,628	2,332,395	2,456,518	3,569,603
Total Common Shares Outstanding